{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:38:08Z","timestamp":1770741488389,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council, New Zealand","doi-asserted-by":"crossref","award":["17\/655"],"award-info":[{"award-number":["17\/655"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["MAUX 1904"],"award-info":[{"award-number":["MAUX 1904"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00213-024-06712-8","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T05:41:48Z","timestamp":1731908508000},"page":"617-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of mixed tobacco monoamine oxidase inhibitors in animal models relevant to tobacco dependence"],"prefix":"10.1007","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-1313","authenticated-orcid":false,"given":"Penelope","family":"Truman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Vivian","family":"Atigari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meyrick","family":"Kidwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Colussi-Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Ellenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"5","key":"6712_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4062\/biomolther.2014.056","volume":"22","author":"HM Ahsan","year":"2014","unstructured":"Ahsan HM, de la Pena JBI, Botanas CJ, Kim HJ, Yu GY, Cheong JH (2014) Conditioned place preference and self-administration induced by nicotine in adolescent and adult rats. Biomol Ther 22(5):460\u2013466. https:\/\/doi.org\/10.4062\/biomolther.2014.056","journal-title":"Biomol Ther"},{"key":"6712_CR2","unstructured":"ASH (2023) ASH Year 10 Snapshot Survey 2023 Topline \u2013 Youth smoking and vaping. . Retrieved from http:\/\/ash.org.nz\/ash_year_10. Accessed 21 Oct 2024"},{"key":"6712_CR3","doi-asserted-by":"publisher","unstructured":"Baker LK, Mao DY, Chi HR, Govind AP, Vallejo YF, Iacoviello M, ... Vezina P (2013) Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci 37(6):1004\u20131011. https:\/\/doi.org\/10.1111\/ejn.12114","DOI":"10.1111\/ejn.12114"},{"key":"6712_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-540-69248-5_8","volume":"192","author":"DJ Balfour","year":"2009","unstructured":"Balfour DJ (2009) The neuronal pathways mediating the behavioral and addictive properties of nicotine. Handb Exp Pharmacol 192:209\u2013233. https:\/\/doi.org\/10.1007\/978-3-540-69248-5_8","journal-title":"Handb Exp Pharmacol"},{"key":"6712_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","volume":"49","author":"NL Benowitz","year":"2009","unstructured":"Benowitz NL (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57\u201371. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094742","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"24","key":"6712_CR6","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra0809890","volume":"362","author":"NL Benowitz","year":"2010","unstructured":"Benowitz NL (2010) Nicotine addiction. N Engl J Med 362(24):2295\u20132303. https:\/\/doi.org\/10.1056\/NEJMra0809890","journal-title":"N Engl J Med"},{"issue":"3","key":"6712_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/22115560113029990004","volume":"2","author":"KA Brennan","year":"2013","unstructured":"Brennan KA, Putt F, Roper V, Waterhouse U, Truman P (2013) Nicotine and tobacco particulate self-administration: effects of mecamylamine SCH23390and ketanserin pretreatment. Curr Psychopharmacol 2(3):229\u2013240. https:\/\/doi.org\/10.2174\/22115560113029990004","journal-title":"Curr Psychopharmacol"},{"issue":"4","key":"6712_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00213-013-3071-3","volume":"228","author":"KA Brennan","year":"2013","unstructured":"Brennan KA, Putt F, Truman P (2013b) Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats. Psychopharmacology 228(4):659\u2013672. https:\/\/doi.org\/10.1007\/s00213-013-3071-3","journal-title":"Psychopharmacology"},{"issue":"2","key":"6712_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/adb.12099","volume":"20","author":"KA Brennan","year":"2015","unstructured":"Brennan KA, Crowther A, Putt F, Roper V, Waterhouse U, Truman P (2015) Tobacco particulate matter self-administration in rats: differential effects of tobacco type. Addict Biol 20(2):227\u2013235. https:\/\/doi.org\/10.1111\/adb.12099","journal-title":"Addict Biol"},{"key":"6712_CR10","doi-asserted-by":"publisher","first-page":"1064211","DOI":"10.3389\/fpsyt.2022.1064211","volume":"13","author":"D Carreno","year":"2022","unstructured":"Carreno D, Lotfipour S (2022) Sex- and genotype-dependent nicotine plus cue-primed reinstatement is enhanced in adolescent Sprague Dawley rats containing the human CHRNA6 3\u2019-UTR polymorphism (rs2304297). Front Psychiatry 13:1064211. https:\/\/doi.org\/10.3389\/fpsyt.2022.1064211","journal-title":"Front Psychiatry"},{"issue":"8","key":"6712_CR11","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/npp.2014.31","volume":"39","author":"MR Costello","year":"2014","unstructured":"Costello MR, Reynaga DD, Mojica CY, Zaveri NT, Belluzzi JD, Leslie FM (2014) Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats. Neuropsychopharmacol 39(8):1843\u20131851. https:\/\/doi.org\/10.1038\/npp.2014.31","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"6712_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14622200601078277","volume":"9","author":"JR DiFranza","year":"2007","unstructured":"DiFranza JR, Wellman RJ (2007) Sensitization to nicotine: how the animal literature might inform future human research. Nicotine Tob Res 9(1):9\u201320. https:\/\/doi.org\/10.1080\/14622200601078277","journal-title":"Nicotine Tob Res"},{"key":"6712_CR13","doi-asserted-by":"publisher","first-page":"925272","DOI":"10.3389\/fnmol.2022.925272","volume":"15","author":"Z Ding","year":"2022","unstructured":"Ding Z, Li X, Chen H, Hou H, Hu Q (2022) Harmane potentiates nicotine reinforcement through MAO-A inhibition at the dose related to cigarette smoking. Front Mol Neurosci 15:925272. https:\/\/doi.org\/10.3389\/fnmol.2022.925272","journal-title":"Front Mol Neurosci"},{"key":"6712_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuropharm.2016.06.026","volume":"109","author":"CA Gellner","year":"2016","unstructured":"Gellner CA, Belluzzi JD, Leslie FM (2016) Self-administration of nicotine and cigarette smoke extract in adolescent and adult rats. Neuropharmacology 109:247\u2013253. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.026","journal-title":"Neuropharmacology"},{"key":"6712_CR15","doi-asserted-by":"publisher","first-page":"1096213","DOI":"10.3389\/fpsyt.2023.1096213","volume":"14","author":"CA Gellner","year":"2023","unstructured":"Gellner CA, Carreno D, Belluzzi JD, Leslie FM (2023) Impact of tobacco smoke constituents on nicotine-seeking behavior in adolescent and adult male rats. Front Psychiatry 14:1096213. https:\/\/doi.org\/10.3389\/fpsyt.2023.1096213","journal-title":"Front Psychiatry"},{"key":"6712_CR16","doi-asserted-by":"publisher","unstructured":"Gomes MN, Reid JL, Rynard VL, East KA, Goniewicz ML, Piper ME, Hammond D (2024) Comparison of indicators of dependence for vaping and smoking: trends between 2017 and 2022 among youth in Canada, England and the United States. Nicotine Tob Res. https:\/\/doi.org\/10.1093\/ntr\/ntae060","DOI":"10.1093\/ntr\/ntae060"},{"issue":"38","key":"6712_CR17","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1523\/JNEUROSCI.2139-05.2005","volume":"25","author":"K Guillem","year":"2005","unstructured":"Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25(38):8593\u20138600. https:\/\/doi.org\/10.1523\/JNEUROSCI.2139-05.2005","journal-title":"J Neurosci"},{"issue":"2","key":"6712_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.biopsych.2007.04.029","volume":"63","author":"K Guillem","year":"2008","unstructured":"Guillem K, Vouillac C, Koob GF, Cador M, Stinus L (2008) Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion. Biol Psychiat 63(2):158\u2013163. https:\/\/doi.org\/10.1016\/j.biopsych.2007.04.029","journal-title":"Biol Psychiat"},{"key":"6712_CR19","doi-asserted-by":"publisher","unstructured":"Hall BJ, Wells C, Allenby C, Lin MY, Hao I, Marshall L, ... Levin ED (2014) Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats. Pharmacol Biochem Behav 120:103\u2013108. https:\/\/doi.org\/10.1016\/j.pbb.2014.02.011","DOI":"10.1016\/j.pbb.2014.02.011"},{"issue":"5","key":"6712_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/ntr\/ntv245","volume":"18","author":"RC Hogg","year":"2016","unstructured":"Hogg RC (2016) Contribution of monoamine oxidase inhibition to tobacco dependence: a review of the evidence. Nicotine Tob Res 18(5):509\u2013523. https:\/\/doi.org\/10.1093\/ntr\/ntv245","journal-title":"Nicotine Tob Res"},{"key":"6712_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuro.2022.09.008","volume":"93","author":"SW Hong","year":"2022","unstructured":"Hong SW, Teesdale-Spittle P, Page R, Truman P (2022) A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke. Neurotoxicology 93:163\u2013172. https:\/\/doi.org\/10.1016\/j.neuro.2022.09.008","journal-title":"Neurotoxicology"},{"key":"6712_CR22","unstructured":"Hong SW (2023) Biochemical characterisation of six novel monoamine oxidase inhibitors identified in tobacco smoke. (PhD). Massey University"},{"issue":"e1","key":"6712_CR23","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1136\/tc-2022-057405","volume":"33","author":"N Krishnan","year":"2024","unstructured":"Krishnan N, Berg CJ, Elmi AF, Klemperer EM, Sherman SE, Abroms LC (2024) Trajectories of ENDS and cigarette use among dual users: analysis of waves 1 to 5 of the PATH Study. Tob Control 33(e1):e62\u2013e68. https:\/\/doi.org\/10.1136\/tc-2022-057405","journal-title":"Tob Control"},{"key":"6712_CR24","doi-asserted-by":"publisher","unstructured":"Lallai V, Chen YC, Roybal MM, Kotha ER, Fowler JP, Staben A, ... Fowler CD (2021) Nicotine e-cigarette vapor inhalation and self-administration in a rodent model: Sex- and nicotine delivery-specific effects on metabolism and behavior. Addict Biol. https:\/\/doi.org\/10.1111\/adb.13024","DOI":"10.1111\/adb.13024"},{"issue":"3\u20134","key":"6712_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00213-005-0155-8","volume":"184","author":"B Le Foll","year":"2006","unstructured":"Le Foll B, Goldberg SR (2006) Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology 184(3\u20134):367\u2013381. https:\/\/doi.org\/10.1007\/s00213-005-0155-8","journal-title":"Psychopharmacology"},{"key":"6712_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-540-69248-5_12","volume":"192","author":"B Le Foll","year":"2009","unstructured":"Le Foll B, Goldberg SR (2009) Effects of nicotine in experimental animals and humans: an update on addictive properties. Handb Exp Pharmacol 192:335\u2013367. https:\/\/doi.org\/10.1007\/978-3-540-69248-5_12","journal-title":"Handb Exp Pharmacol"},{"key":"6712_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuro.2006.05.019","volume":"28","author":"AJ Lewis","year":"2007","unstructured":"Lewis AJ, Miller JH, Lea RA (2007) Monoamine oxidase and tobacco dependence. Neurotoxicology 28:182\u2013195. https:\/\/doi.org\/10.1016\/j.neuro.2006.05.019","journal-title":"Neurotoxicology"},{"key":"6712_CR28","doi-asserted-by":"publisher","unstructured":"Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, ... Hartmann-Boyce J (2024) Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 1(1):CD010216. https:\/\/doi.org\/10.1002\/14651858.CD010216.pub8","DOI":"10.1002\/14651858.CD010216.pub8"},{"key":"6712_CR29","doi-asserted-by":"publisher","first-page":"745783","DOI":"10.3389\/fnins.2021.745783","volume":"15","author":"JK Moen","year":"2021","unstructured":"Moen JK, Lee AM (2021) Sex differences in the nicotinic acetylcholine receptor system of rodents: impacts on nicotine and alcohol reward behaviors. Front Neurosci 15:745783. https:\/\/doi.org\/10.3389\/fnins.2021.745783","journal-title":"Front Neurosci"},{"issue":"3","key":"6712_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0160-5402(85)90021-x","volume":"13","author":"A Morinan","year":"1985","unstructured":"Morinan A, Garratt HM (1985) An improved fluorimetric assay for brain monoamine oxidase. J Pharmacol Methods 13(3):213\u2013223. https:\/\/doi.org\/10.1016\/0160-5402(85)90021-x","journal-title":"J Pharmacol Methods"},{"key":"6712_CR31","unstructured":"Niraula P (2023) The effect of tobacco particulate matter and its components on monoamine oxidase in brain SH-SY5Y Cells. (PhD). Massey University"},{"key":"6712_CR32","unstructured":"Office of Health Improvement and Disparities (2022) Nicotine vaping in England: 2022 evidence update summary. Retrieved from https:\/\/www.gov.uk\/government\/publications\/nicotine-vaping-in-england-2022-evidence-update. Accessed 21 Oct 2024"},{"issue":"1","key":"6712_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","volume":"66","author":"NR Richardson","year":"1996","unstructured":"Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66(1):1\u201311. https:\/\/doi.org\/10.1016\/0165-0270(95)00153-0","journal-title":"J Neurosci Methods"},{"key":"6712_CR34","unstructured":"Rodgman A, Perfetti TA (2013) The chemical components of tobacco and tobacco smoke (2nd ed.): CRC Press."},{"issue":"3\u20134","key":"6712_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","volume":"184","author":"JE Rose","year":"2006","unstructured":"Rose JE (2006) Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 184(3\u20134):274\u2013285. https:\/\/doi.org\/10.1007\/s00213-005-0250-x","journal-title":"Psychopharmacology"},{"key":"6712_CR36","volume-title":"Monoamine oxidase inhibitors : clinical pharmacology, benefits, and potential health risks","author":"S Sharama","year":"2016","unstructured":"Sharama S (2016) Monoamine oxidase inhibitors\u202f: clinical pharmacology, benefits, and potential health risks. Nova Science Publishers Inc, New York"},{"issue":"3\u20134","key":"6712_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/BF02245221","volume":"113","author":"M Shoaib","year":"1994","unstructured":"Shoaib M, Stolerman IP, Kumar RC (1994) Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology 113(3\u20134):445\u2013452. https:\/\/doi.org\/10.1007\/BF02245221","journal-title":"Psychopharmacology"},{"issue":"9","key":"6712_CR38","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1038\/npp.2016.36","volume":"41","author":"TT Smith","year":"2016","unstructured":"Smith TT, Rupprecht LE, Cwalina SN, Onimus MJ, Murphy SE, Donny EC, Sved AF (2016) Effects of monoamine oxidase inhibition on the reinforcing properties of low-dose nicotine. Neuropsychopharmacology 41(9):2335\u20132343. https:\/\/doi.org\/10.1038\/npp.2016.36","journal-title":"Neuropsychopharmacology"},{"key":"6712_CR39","doi-asserted-by":"publisher","unstructured":"Smith TT, Schaff MB, Rupprecht LE, Schassburger RL, Buffalari DM, Murphy SE, ... Donny EC (2015) Effects of MAO inhibition and a combination of minor alkaloids, beta-carbolines, and acetaldehyde on nicotine self-administration in adult male rats. Drug Alcohol Depend 155:243\u2013252. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.07.002","DOI":"10.1016\/j.drugalcdep.2015.07.002"},{"key":"6712_CR40","doi-asserted-by":"publisher","first-page":"886496","DOI":"10.3389\/fnins.2022.886496","volume":"16","author":"AF Sved","year":"2022","unstructured":"Sved AF, Weeks JJ, Grace AA, Smith TT, Donny EC (2022) Monoamine oxidase inhibition in cigarette smokers: from preclinical studies to tobacco product regulation. Front Neurosci 16:886496. https:\/\/doi.org\/10.3389\/fnins.2022.886496","journal-title":"Front Neurosci"},{"key":"6712_CR41","doi-asserted-by":"publisher","first-page":"1119538","DOI":"10.3389\/fnmol.2023.1119538","volume":"16","author":"P Truman","year":"2023","unstructured":"Truman P (2023) Commentary: harmane potentiates nicotine reinforcement through MAO-A inhibition at the dose related to cigarette smoking. Front Mol Neurosci 16:1119538. https:\/\/doi.org\/10.3389\/fnmol.2023.1119538","journal-title":"Front Mol Neurosci"},{"key":"6712_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuro.2016.12.010","volume":"59","author":"P Truman","year":"2017","unstructured":"Truman P, Grounds P, Brennan KA (2017) Monoamine oxidase inhibitory activity in tobacco particulate matter: are harman and norharman the only physiologically relevant inhibitors? Neurotoxicology 59:22\u201326. https:\/\/doi.org\/10.1016\/j.neuro.2016.12.010","journal-title":"Neurotoxicology"},{"issue":"6","key":"6712_CR43","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.neuropharm.2007.02.001","volume":"52","author":"AS Villegier","year":"2007","unstructured":"Villegier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM (2007) Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52(6):1415\u20131425. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.02.001","journal-title":"Neuropharmacology"},{"issue":"8","key":"6712_CR44","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/08870446.2017.1325890","volume":"32","author":"R West","year":"2017","unstructured":"West R (2017) Tobacco smoking: health impact, prevalence, correlates and interventions. Psychol Health 32(8):1018\u20131036. https:\/\/doi.org\/10.1080\/08870446.2017.1325890","journal-title":"Psychol Health"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06712-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T03:09:42Z","timestamp":1740539382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06712-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6712"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06712-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}